The purpose of this study is to evaluate the feasibility and security of the autologous e-ASC for the urinary incontinence after a radical prostate cancer surgery
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
10
Inject in muscle of autologous adipose derived stem cells
Hospital Universitario La Paz
Madrid, Madrid, Spain
Evaluate the feasibility and security of the autologous e-ASC for the urinary incontinence after a radical prostate cancer surgery
Possibility of inject ASc by cystoscope
Time frame: 16 weeks
Quality of life assessment using the SF-12 Questionnaire
SF-12 questionnaire
Time frame: 1, 4, 16, 24 weeks
Adverse events
Data collected
Time frame: 1, 4, 16, 24 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.